ESC 365 - A novel anti-arrhythmic drug: the TASK-1 channel tale.

ESC Premium Access

A novel anti-arrhythmic drug: the TASK-1 channel tale.

Session: Translating Basic Science Discoveries into Clinical Practice

Topic: Basic Science, Other

Speaker: Professor C. Schmidt (Heidelberg, DE)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Constanze Schmidt

University Hospital Heidelberg, Heidelberg (Germany)

5 presentations

0 follower

3 more presentations in this session

Dietary spermidine: a story of cardioprotection and longevity.

Speaker: Doctor M. Abdellatif (Graz, AT)

Mutant KCNJ3 and KCNJ5 potassium channels as novel molecular targets in bradyarrhythmias and atrial fibrillation.

Speaker: Doctor N. Yamada (Suita, JP)

Activation of invariant natural killer T cells for heart failure therapy.

Speaker: Doctor M. Ikeda (Fukuoka, JP)

Access the full session

Translating Basic Science Discoveries into Clinical Practice

Speakers: Professor C. Schmidt, Doctor M. Abdellatif, Doctor N. Yamada, Doctor M. Ikeda

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources